Abstract

Background Gastrointestinal stromal tumors are mesenchymal neoplasms of the gastrointestinal tract, arising from the muscular layer. Revent immunohistochemical studies have shown that up to 94% of GISTs express 117, and 60–70% of GISTs stain for CD 34. GISTs account for 1% of all malignant tumors of gastrointestinal tract; they arise from stomach in the 40–60% of cases whereas they account only for 3% of gastric malignant neoplasms. GISTs can occur at any age but onset most commonly in the sixth and the seventh decades of life.

Highlights

  • Gastrointestinal stromal tumors are mesenchymal neoplasms of the gastrointestinal tract, arising from the muscular layer

  • XI Annual Meeting of The Italian Society of Geriatric Surgery Francesco Sciannameo, Giammario Giustozzi and Beatrice Sensi Publication of this supplement was made possible with support from the Fondazione Cassa di Risparmio di Terni e Narni Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2318-9-S1

  • GISTs account for 1% of all malignant tumors of gastrointestinal tract; they arise from stomach in the 40–60% of cases whereas they account only for 3% of gastric malignant neoplasms

Read more

Summary

Open Access

Address: Department of Surgical Sciences, University of Insubria, Varese, Italy * Corresponding author from XXI Annual Meeting of The Italian Society of Geriatric Surgery Terni, Italy. Published: 1 April 2009 BMC Geriatrics 2009, 9(Suppl 1):A27 doi:10.1186/1471-2318-9-S1-A27. XI Annual Meeting of The Italian Society of Geriatric Surgery Francesco Sciannameo, Giammario Giustozzi and Beatrice Sensi Publication of this supplement was made possible with support from the Fondazione Cassa di Risparmio di Terni e Narni Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2318-9-S1-

Background
Results
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call